Identification of PDL1-Related Biomarkers to Select Lung Adenocarcinoma Patients for PD1/PDL1 Inhibitors

PD1/PDL1 inhibitors have been adopted for the treatment of advanced non-small-cell lung cancer, and PDL1 expression has been investigated as a predictive biomarker for PD1/PDL1 inhibitor therapy. However, PDL1 lacks diagnostic accuracy in differentiating patients who are likely or unlikely to benefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yanping, Lin, Lianjun, Liu, Xinmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303743/
https://www.ncbi.nlm.nih.gov/pubmed/32587640
http://dx.doi.org/10.1155/2020/7291586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303743/
https://www.ncbi.nlm.nih.gov/pubmed/32587640
http://dx.doi.org/10.1155/2020/7291586

Ejemplares similares